Carisma Therapeutics raises $47M in Series B round as company reaches 'key inflection point'

The immunotherapy company in screening cancer patients for its first human drug study.

Source: bizjournals.com Health Care:Physician Practices headlines - January 7, 2021 Category: American Health Authors: John George Source Type: news